Trump Announces Two Rules Aimed at Lowering Drug Prices
President Trump on Friday announced two major actions aimed at reducing the cost of prescription drugs. One action, the ‘Favored [...]
ICER and Other Stakeholders address High Cost of Rare Disease Therapy
At the AMCP Nexus 2020 Virtual meeting, two major themes emerged from the specialty pharmacy practice sessions: new methods for [...]
[Podcast] From Pharma to the Medicine Cabinet: Who Manages the Drugs?
Drugmakers, pharmacies, wholesale distributors, physicians, pharmacy benefit managers—the world of prescription drugs can seem extraordinarily complex. In Episode 3 of [...]
Medical Affairs Mentorship Program Accepting Applications
The Medical Affairs Professional Society (MAPS) Mentorship Program is now accepting applications for mentors and mentees. Application deadline is December 18 [...]
New Data Shows Virtual Technologies Key to Competitive Edge
A September 2020 survey of nearly 100 specialty pharmacy and home infusion providers from SmartBrief and Citus Health reveals new [...]
The Rebate Rule is Back
On Friday, Trump revived the once-scrapped plan to eliminate rebates that drugmakers pay to pharmacy benefit managers with an executive [...]
Jazz Pharmaceuticals Creates New Education Center for Rare Cancer Patients
Jazz Pharmaceuticals has launched Find the Right Fit, a new digital education hub focused on two rare blood cancer types—myelodysplastic syndrome [...]
Pathways for Regulatory and HTA of Histology Independent Therapies
Histology independent therapies represent a new era in personalized healthcare and drug development while challenging existing diagnostic and value assessment [...]
[Podcast] The Straight Dope on Hospital and Payer Transparency Rules
Three transparency rules have come out of CMS in the past months. The first was announced last year, and it [...]
Beyond COVID-19: Life sciences reimagined
Every biopharma function has had to evaluate and adapt its roles and responsibilities almost overnight. So, how do we navigate [...]
Digital Therapeutics and Payers
The DTx market has grown more than 50% over the last 3 years, with many new technologies entering the market. [...]
The Syneos Health Podcast: Payer Power, Part 2
This episode of the Payer Power Podcast explores the impact of strategies payers were starting to bring to the marketplace [...]
Women in HEOR: Adapting to the New Normal
The COVID-19 pandemic has changed the lives of professionals worldwide, with working from home or remotely being the “new normal.” [...]
Surprise Federal Drug Rule Requires Price Transparency from Insurers
Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public [...]
ICER Recommendations Can Be Influenced With the Right Evidence
Based on previous ICER reports, when a pharma product goes through an ICER assessment, there is an extremely high chance [...]
A Patient-centered Look at Specialty Rx Abandonment
Prescription abandonment, when the patient does not fill or pick up a prescription, exacts a heavy financial and human toll [...]
Syneos Health Podcast: Payer Power
Keith Kelly, Senior Managing Director, Value, Access and HEOR at Syneos Health, asserts that the entirety of the US healthcare [...]
The Benefits of Continuous AI Reprioritization in Systematic Reviews
Systematic reviews are a time-consuming and resource-intensive process; even small projects can take several months to complete. , Today there [...]
London School of Hygiene and Tropical Medicine and iDSI Launch COVID-related Platform for HEOR Professionals
The iDSI (International Decision Support Initiative) and London School of Hygiene and Tropical Medicine (LSHTM) just announced the launch of [...]
Rob Barker Appointed CEO of OPEN Health Group
Rob Barker will be succeeding David Rowley as Chief Executive Officer of leading multi-disciplinary health communications and market access group [...]
Minimizing Risk & Accelerating Timelines in Oncology Trials
Cancer has an etiology that involves a wide range of genetic interactions and dysfunction across multiple systems. These characteristics make [...]
Free Medical Science Liaison (MSL) and MSL Manager Mentor Program
The MSL Mentor Program is a unique program, provided free of charge, that exemplifies The Medical Science Liaison Society's mission [...]
[Webinar] Conducting Qualification and Validation in the Era of Covid-19
In a process known as qualification and validation, regulatory agencies such as FDA, EMA and WHO, require that the pharmaceutical, [...]
[Whitepaper] How Can Real-World Evidence Support Adoption of New Technology?
The application of real-world evidence (RWE) as a healthcare decision-making tool has the potential to significantly improve patient outcomes, patient [...]
Bayesian Methods for Multiple Cohort Expansion (MuCE) designs
Cohort expansion trials where multiple dose(s) and multiple indication(s) need to be tested in parallel can present complex problems for [...]